Table 3.
I2 | k | N | FSN | r | 95% CI | z(SE) | Q(w) | Q(b) (p-val) | ||
---|---|---|---|---|---|---|---|---|---|---|
Mindfulness Facet | 12.28 | 61 | 14895 | 311 | −0.10* | −0.13, −0.06 | −5.31 (0.02) | 59.97 | 8.42 (0.08) | |
OBS | 11 | 2705 | 0.004 | −0.08, 0.09 | 0.09 (0.04) | |||||
DES | 11 | 2705 | −0.07 | −0.16, 0.01 | −1.70 (0.04) | |||||
AWA | 12 | 2917 | −0.13* | −0.21, −0.05 | −3.22 (0.04) | |||||
NJUD | 15 | 3440 | −0.15* | −0.22, −0.07 | −3.93 (0.04) | |||||
NRE | 12 | 3128 | −0.11* | −0.20, −0.03 | −2.80 (0.04) | |||||
Substance Severity | 53 | 14136 | 288 | −0.13* | −0.16, −0.10 | −8.37 (0.02) | 48.43 | 5.17 (0.02) | ||
NPROB | 32 | 12015 | −0.10* | −0.14, −0.06 | −4.96 (0.02) | |||||
PROB | 21 | 5906 | −0.18* | −0.23, −0.13 | −7.12 (0.02) | |||||
Substance Type | 15.41 | 43 | 14938 | 250 | −0.11* | −0.14, −0.08 | −7.45 (0.01) | 42.86 | 6.79 (0.03) | |
ALC | 25 | 5195 | −0.12* | −0.16, −0.09 | −6.44 (0.02) | |||||
MJ | 6 | 1877 | −0.01 | −0.09, 0.06 | −0.37 (0.04) | |||||
CIGS | 12 | 7220 | −0.13* | −0.18, −0.07 | −4.54 (0.03) | |||||
Clinical Status | 34.43 | 39 | 14136 | 288 | −0.13* | −0.17, −0.10 | −8.38 (0.02) | 40.48 | 17.47 (<0.001) | |
NC | 29 | 11711 | −0.11* | −0.14, −0.07 | −5.76 (0.02) | |||||
OUT | 7 | 1951 | −0.12* | −0.25, −0.10 | −4.53 (0.04) | |||||
IN | 3 | 474 | −0.38* | −0.51, −0.25 | −5.83 (0.07) |
Note. Substance Type: ALC-alcohol; MJ-marijuana; CIGS-cigarettes. Clinical Status: NC-nonclinical; OUT-outpatient; IN-inpatient. Mindfulness Facets: OBS-observing; DES-describing; AWA-awareness; NJUD-non-judgment; NRE-non-reactivity. Substance Severity: NPROB-non-problematic substance use behaviors; PROB-problematic substance use behaviors.
indicates p < 0.05.
I2: heterogeneity analysis using I2 index; k: number of publications; N: sample size; FSN: fail-safe N; r: aggregate r value; 95% CI: 95% confidence interval; z(SE): z-score and standard error; Q(w): variance within group means; Q(b): variance between group means.